Brief: Xilio Therapeutics Announces Third Quarter Results
09/11/2022 15:20
Nov 9 (Reuters) - Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS ANNOUNCES PIPELINE AND BUSINESS UPDATES
AND
THIRD QUARTER 2022 FINANCIAL RESULTS
* XILIO THERAPEUTICS INC - ANTICIPATES EXISTING CASH AND
EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATING EXPENSES AND
CAPEX REQUIREMENTS INTO Q2 2024
* XILIO THERAPEUTICS INC QTRLY NET LOSS PER SHARE $0.72
Source text for Eikon: ID:nGNX1DfPkc
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla